Filgrastim biosimilar (Bionaturis)

非格司亭生物类似药（Bionaturis）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Bionaturis)

Drug Alias Name非格司亭生物仿制药（Bionaturis）rhG-CSF (Bionaturis)Recombinant human granulocyte macrophage colony stimulating factor (Bionaturis)重组人粒细胞刺激因子（Bionaturis）

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsLysosomal Storage DiseasesNeutropenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBionaturis

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBionaturis

Active IndicationsN/A

Inactive IndicationsLysosomal Storage DiseasesNeutropenia

Other Information

ATC CodeL03AA02